Impact of Bean Polyphenols and Phytic Acid on Iron Absorption

NCT ID: NCT01472484

Last Updated: 2012-06-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-12-31

Study Completion Date

2012-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Recently isolated low PA varieties (lpa) in wheat, rice, maize, barley and beans might have the potential to alleviate iron bioavailability problems associated with PA. These plants have normal phosphate levels, but reduced PA phosphate due to various modifications of the biosynthetic pathway of PA. So far lpa crops are in an early stage of development, most of them exhibiting reduced yield and seed germination. However, the lpa bean isolated by Campion and co-workers 2009 by chemical mutagenesis exhibited only 10 % of the native bean PA concentration without any defects in terms of growth and yield.

Crossing the lpa variety with bean varieties low in PP and high in iron might lead to the development of a variety which has the potential to improve the iron status of bean consuming populations.

The following study will evaluate the relative impact of PA and PP on iron absorption from beans by comparing iron absorption from four different bean varieties. Iron absorption from a bean with normal PA concentration and high PP concentration will be compared to iron absorption from a bean with normal PA and low PP concentration as well as to two lpa varieties, one with high and one with low PP concentration.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Blood Iron Isotope Enrichment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

lpa with high polyphenol

Group Type EXPERIMENTAL

586/8x87 brown

Intervention Type OTHER

2 x 50 g

lpa with low polyphenol

Group Type EXPERIMENTAL

586/8x87 white

Intervention Type OTHER

2 x 50 g

control bean with low polyphenol

Group Type EXPERIMENTAL

586/8

Intervention Type OTHER

2 x 50 g

control bean with high polyphenol

Group Type EXPERIMENTAL

BAT 881

Intervention Type OTHER

2 x 50 g

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

586/8x87 white

2 x 50 g

Intervention Type OTHER

586/8x87 brown

2 x 50 g

Intervention Type OTHER

BAT 881

2 x 50 g

Intervention Type OTHER

586/8

2 x 50 g

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Non-pregnant, non-lactating women
* Between 18 and 40 years
* Below 65kg

Exclusion Criteria

* Metabolic, chronic and gastro-intestinal disease
* Long-term medication
* Blood donation within 6 month before the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Swiss Federal Institute of Technology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prof. Michael B. Zimmermann

Prof

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Richard Hurrell, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

ETH Zürich

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

ETH

Zurich, Canton of Zurich, Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Petry N, Egli I, Campion B, Nielsen E, Hurrell R. Genetic reduction of phytate in common bean (Phaseolus vulgaris L.) seeds increases iron absorption in young women. J Nutr. 2013 Aug;143(8):1219-24. doi: 10.3945/jn.113.175067. Epub 2013 Jun 19.

Reference Type DERIVED
PMID: 23784069 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

lpa_586/8X87

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dietary Iron Requirements
NCT07139821 NOT_YET_RECRUITING
Oat Phenolics Bioavailability
NCT02574039 COMPLETED NA
Barley Protein and CVD
NCT00334308 COMPLETED PHASE2